Evidence map›Paper›PMID 35267302›Full record

ArticleFoods (Basel, Switzerland)2022

Dissipation and Residues of Pyraclostrobin in

Lei Han, Qiong Wu, Xiaomao Wu

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lei HanInstitute of Crop Protection, Guizhou University, Guiyang 550025, China.
Qiong WuPlant Protection and Plant Inspection Station of Guizhou Province, Guiyang 550001, China.
Xiaomao WuInstitute of Crop Protection, Guizhou University, Guiyang 550025, China.
Guizhou University · CNGuizhou Institute of Plant Protection · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosa roxburghii has been widely planted in China. Powdery mildew is the most serious disease of R. roxburghii cultivation. Pyraclostrobin was widely used as a novel fungicide to control powdery mildew of R. roxburghii. To assess the safety of pyraclostrobin for use on R. roxburghii fruits, its residue rapid analysis as well as an investigation on its dissipation behaviors and terminal residues in R. roxburghii and soil under field conditions were carried out. The QuEChERS method was simplified using LC−MS/MS detection and combined with liquid−liquid extraction purification to allow determination of pyraclostrobin levels in R. roxburghii fruits and the soil. The fortified recoveries at 0.1~5.0 mg/kg were 93.48~102.48%, with the relative standard deviation of 0.64~3.21%. The limit of detection of the analytical method was 0.16 and 0.15 µg/kg for R. roxburghii fruit and soil, respectively. The effects of different spray equipment and formulations on the persistence of pyraclostrobin in R.roxburghii were as follows: gaston gasoline piggyback agricultural sprayer (5.38 d) > manual agricultural backpack sprayer (3.37 d) > knapsack multi-function electric sprayer (2.91 d), suspension concentrate (SC) (6.78 d) > wettable powder (WP) (5.64 d) > water dispersible granule (WG) (4.69 d). The degradation of pyraclostrobin followed the first-order kinetics and its half-lives in R.roxburghii and soil were 6.20~7.79 days and 3.86~5.95 days, respectively. The terminal residues of pyraclostrobin in R. roxburghii and soil were 0.169~1.236 mg/kg and 0.105~3.153 mg/kg, respectively. This study provides data for the establishment of the maximum residue limit (MRL) as well as the safe and rational use of pyraclostrobin in R. roxburghii production.

Indexed as

dissipationpyraclostrobinresidueRosa roxburghiisoil

Identifiers

PMID35267302
PMCPMC8909010
OpenAlexW4214636754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.